Ore Pharmaceuticals has appointed Benjamin Palleiko as senior vice president and chief financial officer. Palleiko will lead all corporate financial activities, as well as work with the rest of the management team to drive Ore’s strategy and growth. He will be based in Cambridge, MA.
Palleiko has lengthy industry experience as both a public pharmaceuticals company CFO and as an investment banker focused on the life sciences sector. Previously, he served as principal of Intrepid Merchant Partners, a healthcare advisory and investments firm he founded in March 2006. From June 2006 to January 2009, Palleiko was senior vice president, corporate development and CFO of Penwest Pharmaceuticals, a publicly held specialty pharmaceuticals company. From March 2003 to March 2006, he served as director, head of Life Sciences Investment Banking at Suntrust Robinson Humphrey, and from 2000 to 2002, he was vice president, Investment Banking at Robertson Stephens.
A report by broking group Marsh examines the repercussions from the administration of the South Korean company, which filed for bankruptcy protection at the end of August.
Global research by C2FO suggests that smaller businesses are less concerned with the repercussions of Brexit and the upcoming US presidential election.
A squeeze on skilled talent means it now takes an average of seven weeks to fill open permanent roles in finance in the UK according to new research from financial services recruitment firm Robert Half.
Early-stage merger and acquisition deals in Asia-Pacific show nearly 10% year-on-year growth in recent months.